← Leaderboards
Bert W O'Malley
Johns Hopkins University
$3,907,445
Attributed
$4,067,445
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $673.6K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$4,067,445 · 7
By mechanism
R01$3,757,148 · 4
R34$200,000 · 1
R29$110,297 · 1
M01$0 · 1
Top collaborators
- Jason A Burdick1 shared
- Anh D Le1 shared
- Thomas P Schaer1 shared
- Songtao Shi1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Young J. Kim$4,039,490
- Se-Jin Lee$17,681,857
- David Sidransky$59,922,938
- Gary W Ketner$3,064,527
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchGene TherapyGene ExpressionHead /Neck NeoplasmHuman SubjectCell LineTumorGenesAdenoviridaeFibroblast Growth FactorFlow CytometryValidationOral Pharyngeal NeoplasmBaseAthymic MouseTissuesMonoclonal AntibodyMorbidity - Disease RateClinical Trial Phase IGene TargetingDrug Screening /EvaluationCancer PatientCellsDrug Adverse Effect
Grant awards (17)
Penn Multidisciplinary Consortium: Personalized Dental, Oral and Craniofacial Tissue Regeneration$200,000
R34 · FY2015 · DE
Molecular Analysis of OSCC Tumor Invasion$391,581
R01 · FY2010 · DE · contact PI
Molecular Analysis of OSCC Tumor Invasion$385,558
R01 · FY2009 · DE · contact PI
Mechanisms of Oral Cancer Motility and Invasion$260,110
R01 · FY2008 · DE · contact PI
Adenovirus Limitations and Tumor Targeted Gene Therapy$375,716
R01 · FY2007 · DE · contact PI
Human and Murine Models of BRCA1 Tumorigenesis$263,002
R01 · FY2007 · CA · contact PI
Adenovirus Limitations and Tumor Targeted Gene Therapy$386,938
R01 · FY2006 · DE · contact PI
Human and Murine Models of BRCA1 Tumorigenesis$270,857
R01 · FY2006 · CA · contact PI
Adenovirus Limitations and Tumor Targeted Gene Therapy$396,250
R01 · FY2005 · DE
Human and Murine Models of BRCA1 Tumorigenesis$277,375
R01 · FY2005 · CA
Adenovirus Limitations and Tumor Targeted Gene Therapy$396,250
R01 · FY2004 · DE
Adenovirus Limitations and Tumor Targeted Gene Therapy$307,257
R01 · FY2003 · DE
Adenovirus Limitations and Tumor Targeted Gene Therapy$46,254
R01 · FY2003 · DE
HIL 2 PLASMID GENE THERAPY PATIENTS WITH SQUAMOUS CELL CARCINOMA$0
M01 · FY2002 · RR
HIL 2 PLASMID GENE THERAPY PATIENTS WITH SQUAMOUS CELL CARCINOMA$0
M01 · FY2001 · RR
GENE THERAPY FOR ORAL CANCER$110,297
R29 · FY2000 · DE
HIL 2 PLASMID GENE THERAPY PATIENTS WITH SQUAMOUS CELL CARCINOMA$0
M01 · FY2000 · RR